Optimizing care for COPD patients

A Clarivate client wanted to improve COPD patient outcomes by identifying high-risk patients and escalating treatment per national clinical guidelines. The company deployed digital messaging embedded in EHR workflows to flag COPD patients on dual therapies who had received oral corticosteroids -- a marker of exacerbation risk -- and guide them toward guideline-recommended triple therapy. The page states the campaign achieved a "31% overall increase in triple therapy prescriptions."

The customer is anonymised in Clarivate’s own case study — not withheld by us.

Clarivate owns Cortellis, the curated competitive-intelligence and pipeline-tracking platform standard in pharma portfolio-management teams.

This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.